Assignee
EYEGENE INC
KR·7 granted patents·6 pending applications·15 citations·filing 2002–2022
Top patents by PatentIndex Score
13 records- 0177US7507802B2Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharidesEYEGENE INC·Filed 2002·Granted Mar 24, 2009·12 cites·11 claims
- 0276US9101581B2Method for treating vascular-related diseaseEYEGENE INC·Filed 2013·Granted Aug 11, 2015·2 cites·3 claims
- 0364US8372811B2Composition for treating retinopathy or glaucoma comprising thrombin derived peptidesEYEGENE INC·Filed 2007·Granted Feb 12, 2013·1 cites·4 claims
- 0452US2024148897A1Composition for in vivo delivery of rna and preperation method thereforEYEGENE INC·Filed 2022·Application pending·0 cites
- 0552US2024165222A1Vaccine composition for preventing sars-cov-2EYEGENE INC·Filed 2021·Application pending·0 cites
- 0651US2021353711A1Pharmaceutical composition for preventing or treating inflammatory diseasesEYEGENE INC·Filed 2019·Application pending·0 cites
- 0750US2009061465A1Composition for analyzing diabetes mellitus and/or retinal vascular disease and analyzing method thereofEYEGENE INC·Filed 2005·Application pending·0 cites
- 0849USRE48023EMethod for treating vascular-related diseaseEYEGENE INC·Filed 2016·Granted Jun 2, 2020·0 cites·19 claims
- 0947US9290542B2Pharmaceutical composition for preventing or treating arteriosclerosisEYEGENE INC·Filed 2013·Granted Mar 22, 2016·0 cites·2 claims
- 1046US2022287970A1Composition for inhibiting saponin-induced hemolysis, containing cationic liposomeEYEGENE INC·Filed 2021·Application pending·0 cites
- 1143US10918709B2Immune modulator and vaccine composition containing the sameEYEGENE INC·Filed 2017·Granted Feb 16, 2021·0 cites·9 claims
- 1243US10874733B2Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of sameEYEGENE INC·Filed 2017·Granted Dec 29, 2020·0 cites·14 claims
- 1342US2008009441A1Polypeptide Inducing the Secretion of AngiopoietinEYEGENE INC·Filed 2004·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →